HRP20120437A2 - Obložena tableta koja sadrži imatinib mesilat, naäśin njezine proizvodnje i primjena - Google Patents

Obložena tableta koja sadrži imatinib mesilat, naäśin njezine proizvodnje i primjena

Info

Publication number
HRP20120437A2
HRP20120437A2 HRP20120437AA HRP20120437A HRP20120437A2 HR P20120437 A2 HRP20120437 A2 HR P20120437A2 HR P20120437A A HRP20120437A A HR P20120437AA HR P20120437 A HRP20120437 A HR P20120437A HR P20120437 A2 HRP20120437 A2 HR P20120437A2
Authority
HR
Croatia
Prior art keywords
tablet
imatinib mesylate
imatinib
pharmaceutical industry
production
Prior art date
Application number
HRP20120437AA
Other languages
English (en)
Inventor
Sahin Hulya
Original Assignee
Teva Canada Limited
Teva Limited Liability Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Canada Limited, Teva Limited Liability Company filed Critical Teva Canada Limited
Publication of HRP20120437A2 publication Critical patent/HRP20120437A2/hr
Publication of HRPK20120437B3 publication Critical patent/HRPK20120437B3/hr

Links

Abstract

Predmetni izum spada u područje medicine, posebno, farmaceutske industrije, te osigurava novi oblik lijeka imatinib mesilata, naime, obložena filmom tableta, jezgra tablete sadrži kao aktivni sastojak kristalni oblik imatinib mesilata, bezvodni dvobazni kalcijev fosfat kao punilo i prihvaćene u farmaceutskoj industriji pomoćne tvari odabrane iz skupine dezintegranata i lubrikanata. Izum također predviđa način proizvodnje tablete i primjenu tablete u liječenju širokog spektra bolesti ili stanja u kojima je indicirana primjena imatiniba. U postupku proizvodnje tablete granule dobivene nakon stadija vlažne granulacije nisu ljepljive i imaju izvrsnu fluidnost i podložnost prešanju u tabletu bez potrebe za korištenjem vezivnih tvari i glidanata. Tableta prema izumu ima otpornost na upijanje atmosferske vlage i visoku stabilnost kod čuvanja.
HRP20120437AA 2011-05-24 2012-05-23 Obložena tableta koja sadrži imatinib mesilat, naäśin njezine proizvodnje i primjena HRPK20120437B3 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201100679A EA017781B1 (ru) 2011-05-24 2011-05-24 Покрытая пленочной оболочкой таблетка, содержащая иматиниб мезилат, и способ ее получения

Publications (2)

Publication Number Publication Date
HRP20120437A2 true HRP20120437A2 (hr) 2013-09-30
HRPK20120437B3 HRPK20120437B3 (hr) 2014-06-06

Family

ID=45908254

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20120437AA HRPK20120437B3 (hr) 2011-05-24 2012-05-23 Obložena tableta koja sadrži imatinib mesilat, naäśin njezine proizvodnje i primjena

Country Status (2)

Country Link
EA (1) EA017781B1 (hr)
HR (1) HRPK20120437B3 (hr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA024165B1 (ru) * 2013-10-31 2016-08-31 Ооо "Тева" Лекарственная форма n-карбамоилметил-4-фенил-2-пирролидона, способ ее получения и применение

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054314A1 (en) * 2004-11-17 2006-05-26 Natco Pharma Limited Polymorphic forms of imatinib mesylate
DE502006005084D1 (de) * 2005-08-15 2009-11-26 Siegfried Generics Int Ag Filmtablette oder Granulat enthaltend ein Pyridylpyrimidin
US20090087489A1 (en) * 2007-09-25 2009-04-02 Bella Gerber Imatinib compositions

Also Published As

Publication number Publication date
HRPK20120437B3 (hr) 2014-06-06
EA201100679A1 (ru) 2012-03-30
EA017781B1 (ru) 2013-03-29

Similar Documents

Publication Publication Date Title
ZA201608614B (en) Solid oral pharmaceutical compositions for isoxazoline compounds
MX2017010858A (es) Composicion para el tratamiento de enfermedades relacionadas con la interleucina 6.
MD20140073A2 (en) New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
TN2019000281A1 (en) Ferroportin-inhibitor salts
EA201691151A1 (ru) Соединения для лечения пациентов с ros1-мутантными раковыми клетками
NZ748351A (en) Manufacturing of semi-plastic pharmaceutical dosage units
CY1122626T1 (el) Κορτικοστεροειδες που περιεχει τις συνθεσεις των δισκιων που διασπωνται απο το στομα για την ηωσινοφιλικη οισοφαγιτιδα
MX2019009777A (es) Sistemas y metodos para la fabricacion de tabletas, que incluyen tabletas farmaceuticas.
MX340188B (es) Elaboracion de granulos sin activos y tabletas que comprenden los mismos.
MX2022015606A (es) Comprimidos de liberacion inmediata que contienen un farmaco y procesos para formar los comprimidos.
DOP2006000113A (es) Formulaciones de ácido hidroxámico suberoilanilida y procedimiemtos para la producción de las mismas
HRP20120437A2 (hr) Obložena tableta koja sadrži imatinib mesilat, naäśin njezine proizvodnje i primjena
SA516370446B1 (ar) تركيبة صيدلانية مستقرة مضادة للدرن في صورة قرص قابل للتشتت يحتوي على حبيبات إيزونيازيد وحبيبات ريفابنتين، وعملية لتحضيرها
MX362485B (es) Nuevos inhibidores de rock.
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
PH12016500120A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
HRPK20120436B3 (hr) Kapsula imatinib mesilata, naäśin njezine proizvodnje i primjena
RU2013107724A (ru) Фармацевтические композиции монтелукаста и левоцетиризина
PH12015502560A1 (en) Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease
EA201600400A1 (ru) Противоопухолевая фармацевтическая композиция, содержащая темозоломид, и способ ее получения
CU24515B1 (es) Formas de dosificación farmacéutica que comprenden 1-[6-(morfolin-4-il) pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1h-pirazol-5-olato de sodio
MX2015016678A (es) Formulaciones farmaceuticas que comprenden agomelatina en forma de cocristal de agomelatina con un acido organico.
PL399712A1 (pl) Sposób wytwarzania tabletki o zwiekszonej dostepnosci farmaceutycznej worykonazolu
PH12016502540A1 (en) Pharmaceutical dosage forms
EA201201372A1 (ru) Способ получения фармацевтической композиции и продукт способа

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AKOB Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent)
PKB1 Consensual patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190430

Year of fee payment: 8

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200518

Year of fee payment: 9

ODRP Renewal fee for the maintenance of a patent

Payment date: 20210517

Year of fee payment: 10

AIPK Request for the grant of a patent on the basis of a substantive examination of a patent application after grant of consensual patent
OBST Application withdrawn
PK10 Patent expired after termination of 10 years for consensual patent

Effective date: 20220523